CN108456262A - A kind of preparation process of high purity heparin sodium - Google Patents

A kind of preparation process of high purity heparin sodium Download PDF

Info

Publication number
CN108456262A
CN108456262A CN201810202915.9A CN201810202915A CN108456262A CN 108456262 A CN108456262 A CN 108456262A CN 201810202915 A CN201810202915 A CN 201810202915A CN 108456262 A CN108456262 A CN 108456262A
Authority
CN
China
Prior art keywords
heparin sodium
oxidation
added
hydrogen peroxide
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810202915.9A
Other languages
Chinese (zh)
Inventor
李海生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGYUAN HAITIAN INDUSTRIAL Co Ltd
Original Assignee
GUANGYUAN HAITIAN INDUSTRIAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGYUAN HAITIAN INDUSTRIAL Co Ltd filed Critical GUANGYUAN HAITIAN INDUSTRIAL Co Ltd
Priority to CN201810202915.9A priority Critical patent/CN108456262A/en
Publication of CN108456262A publication Critical patent/CN108456262A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0081Reaction with amino acids, peptides, or proteins
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The present invention provides a kind of preparation processes of high purity heparin sodium, mainly be dehydrated and be dried in vacuo including the sodium chloride salt solution of 3.0% (w/v), the trypsin digestion of 0.1%~0.2% (w/v), hydrogen peroxide ozone efficient oxidation, absolute ethyl alcohol precipitation, acetone and etc., wherein hydrogen peroxide ozone efficient oxidation system can generate HO2 , it is the inducing agent that free radical OH is generated, free radical OH will cause chain reaction once generating, accelerate oxidation rate, improve oxidation effectiveness.It is compared, has been saved at least 40% time with traditional multistage hydrogen peroxide oxidation using the technique purification heparin sodium described in this programme, potency improves 9U/mg, and the potency rate of recovery improves 8%, and heparin sodium purity obtained is high, and color and luster is good.

Description

A kind of preparation process of high purity heparin sodium
Technical field
The present invention relates to heparin sodium preparation fields, and in particular to a kind of preparation process of high purity heparin sodium.
Background technology
Heparin sodium is the practical widest anticoagulation medicine of clinical medicine domain, it is by D-Glucose amine, N- acetyl Portugal The mucopolysaccharide sulfuric ester that grapes glucosamine, D- glucuronic acids and L- iduronic acids alternately form, is primarily present in pluck Mast cell granule in, mostly combined with protein and existed with Protein-Heparin complexes, mainly in mucous membrane of small intestine and lungs Content highest.Heparin sodium is mainly used for blood coagulation resisting function, is one of the biochemical drug of currently the most important ones anticoagulation and antithrombotic, But heparin sodium be raw material prepare medicament often through injection by way of be administered, so heparin sodium must have it is very high-purity Degree just can guarantee medical safety.
The heparin sodium for preparing high-purity at present is purified on the basis of crude heparin sodium, and the prior art is usually adopted The protein and nucleic acid in crude product are removed with hydrogen peroxide secondary oxidation, process temperature is up to 95 degrees Celsius, and PH is 1.5~2.0 Between, under conditions of such highly acidity and high-temperature, heparin sodium is easy inactivation, and titer of heparin sodium is caused to be lost, and aoxidizes Time is up to 20 hours or more, and production efficiency is low, while hydrogen peroxide use is bigger, and product color is better, but potency is lower. In addition, also there is the prior art to remove the protein nucleic acid in crude product using the method for flocculation sediment and membrane filtration, but it is acid Protein precipitation is not easy to filter out, and leads to filter out that the time is often long, and filter efficiency is low, therefore the prior art is using utilization The glass powder or diatomite of silicone hydroxyl are as filter aid, but the effect is unsatisfactory, while filter aid also has absorption to heparin sodium Effect, can cause the rate of recovery to reduce.Therefore, it is necessary to a kind of high purity heparin sodium preparation processes, to solve prior art preparation The technical issues of long time period, inefficiency, titer of heparin sodium and the rate of recovery are lowered.
Invention content
It is an object of the invention to:A kind of preparation process of high purity heparin sodium, for solving the prior art preparation time The technical issues of long working efficiency is low, and titer of heparin sodium and the rate of recovery reduce.
The technical solution adopted by the present invention is as follows:
A kind of preparation process of high purity heparin sodium, includes the following steps:
(1) proportionally every kilogram of crude heparin sodium is added in 8~10L purified waters and is dissolved, concentration 3.0% is added (w/v) sodium chloride is stirred 45~60 minutes and is filtered, removes the contamination precipitation of precipitation, obtain crude product filtered fluid;
(2) trypsase of 0.1%~0.2% (w/v) is added in the crude product filtered fluid obtained in step (1), adjusts PH values stir 1.5~2 hours, the foreign protein in heparin sodium is degraded to small-molecular peptides by trypsase, simultaneously to 7.5~8.5 Make heparin sodium molecule dissociate from the compound of heparin sodium-protein to come, obtains enzymolysis liquid;
(3) pH value adjustment for the enzymolysis liquid that step (2) obtains will be passed through to 1.5~2.0, after stirring 30~45 minutes, adopted The small-molecular peptides that removal zymoprotein and protein are degraded are centrifuged with high-speed low temperature, it is molten to obtain the few heparin sodium of protein content Liquid;
(4) hydrogen peroxide of 1.5%~2.0% (w/v) is added in the heparin sodium molten night obtained by step (3), and It by pH value adjustment to 8.5~9.5, stirs 3~4 hours, the colors in oxidation removal heparin sodium molten night, then high speed Low-temperature centrifugation obtains heparin sodium oxidation solution;
(5) absolute ethyl alcohol is added in the heparin sodium oxidation solution obtained by step (4), by alcoholic strength according to volume basis Number is adjusted to 55~65 degree, and the sodium chloride of 1.0%~1.5% (w/v) is added in the solution, is stirred 1~1.5 hour and is filtered, Obtain heparin sodium sediment;
(6) acetone is added in the heparin sodium sediment obtained by step (5) to be dehydrated, and by being dried in vacuo, High purity heparin sodium is made.When preparation process using the present invention purifies heparin sodium, compared with conventional multi-level oxidation technology, potency 9U/mg is improved, the potency rate of recovery improves 8%.
Preferably, the hydrogen peroxide of 1.0%~1.5% (w/v) is added in the step (4) heparin sodium molten night, and will PH values are adjusted to 8.5~9.5, then pass to ozonation aerated 2.5~3 hours, form the efficient oxidation body of hydrogen peroxide-ozone It is colors and residual protein in oxidation removal heparin sodium molten night, then high-speed low temperature centrifuges to obtain heparin sodium oxidation Liquid.Hydrogen peroxide-ozone efficient oxidation system can generate HO2 -, it is the inducing agent that free radical OH is generated, free radical OH is once It generates, chain reaction will be caused, accelerate oxidation rate, improve oxidation effectiveness.
Compared to the prior art, the beneficial effects of the invention are as follows:
1. the mode that this programme uses trypsin digestion and level-one hydrogen peroxide oxidation removes albumen in heparin sodium Matter and pigment impurity are compared with traditional multistage hydrogen peroxide oxidation, have saved at least 40% time, improved Working efficiency.In addition, during heparin sodium purifies, the method for using high-speed low temperature centrifugation solves the prior art and adopts With membrane filtration acidic protein precipitation is difficult, time-consuming and ineffective technical problem.Preparation process using the present invention When purifying heparin sodium, compared with conventional multi-level oxidation technology, potency improves 9U/mg, and the potency rate of recovery improves 8%, is made Heparin sodium purity it is high, color and luster is good.
2. HO can be generated using hydrogen peroxide-ozone efficient oxidation system2 -, it is the inducing agent that free radical OH is generated, from By base OH once generating, chain reaction will be caused, accelerate oxidation rate, improve oxidation effectiveness.It is smelly using hydrogen peroxide- The efficient oxidation system of oxygen decolourizes to pigment impurity and is removed residual protein, than simple hydrogen peroxide oxidation ratio Get up, reduce the content of hydrogen peroxide, further improves the recycling potency of heparin sodium, while ozone is in addition to having sterilization to disappear Outside malicious, decolouring and deodorizing function, also there is the advantage that can be aoxidized hardly degraded organic substance and improve flocculating effect etc., and smelly Oxygen will not remain or generate secondary pollution, can further shorten the reaction time, improve working efficiency.
Specific implementation mode
All features disclosed in this specification can be with any other than mutually exclusive feature and/or step Mode combines.
Embodiment 1
A kind of preparation process of high purity heparin sodium, includes the following steps:
(1) proportionally every kilogram of crude heparin sodium is added in 8~10L purified waters and is dissolved, concentration 3.0% is added (w/v) sodium chloride is stirred 45~60 minutes and is filtered, removes the contamination precipitation of precipitation, obtain crude product filtered fluid;
(2) trypsase of 0.1%~0.2% (w/v) is added in the crude product filtered fluid obtained in step (1), adjusts PH values stir 1.5~2 hours, the foreign protein in heparin sodium is degraded to small-molecular peptides by trypsase, simultaneously to 7.5~8.5 Make heparin sodium molecule dissociate from the compound of heparin sodium-protein to come, obtains enzymolysis liquid;
(3) pH value adjustment for the enzymolysis liquid that step (2) obtains will be passed through to 1.5~2.0, after stirring 30~45 minutes, adopted The small-molecular peptides that removal zymoprotein and protein are degraded are centrifuged with high-speed low temperature, it is molten to obtain the few heparin sodium of protein content Liquid;
(4) hydrogen peroxide of 1.5%~2.0% (w/v) is added in the heparin sodium molten night obtained by step (3), and It by pH value adjustment to 8.5~9.5, stirs 3~4 hours, the colors in oxidation removal heparin sodium molten night, then high speed Low-temperature centrifugation obtains heparin sodium oxidation solution;
(5) absolute ethyl alcohol is added in the heparin sodium oxidation solution obtained by step (4), by alcoholic strength according to volume basis Number is adjusted to 55~65 degree, and the sodium chloride of 1.0%~1.5% (w/v) is added in the solution, is stirred 1~1.5 hour and is filtered, Obtain heparin sodium sediment;
(6) acetone is added in the heparin sodium sediment obtained by step (5) to be dehydrated, and by being dried in vacuo, High purity heparin sodium is made.
Technique of the present invention uses trypsin digestion and the mode of level-one hydrogen peroxide oxidation removes heparin sodium In protein and pigment impurity, compared with traditional multistage hydrogen peroxide oxidation, saved at least 40% when Between, it improves work efficiency.In addition, during heparin sodium purifies, the method for using high-speed low temperature centrifugation solves existing There is technology using membrane filtration acidic protein precipitation difficulty, time-consuming and ineffective technical problem.It is using the present invention When preparation process purifies heparin sodium, compared with conventional multi-level oxidation technology, potency improves 9U/mg, and the potency rate of recovery improves 8%.
Embodiment 2
Embodiment 2 is theed improvement is that the improvement of embodiment 1:In step (4) described in embodiment 1, in heparin sodium The hydrogen peroxide of 1.0%~1.5% (w/v) is added in molten night, and by pH value adjustment to 8.5~9.5, then passes to ozonation aerated 2.5~3 hours, form the efficient oxidation system of hydrogen peroxide-ozone, colors in oxidation removal heparin sodium molten night and Residual protein, then high-speed low temperature centrifuge to obtain heparin sodium oxidation solution.
It is decolourized and is removed to pigment impurity residual protein using the efficient oxidation system of hydrogen peroxide-ozone, than Simple hydrogen peroxide oxidation is compared, and the content of hydrogen peroxide is reduced, and further improves the recycling effect of heparin sodium Valence, while ozone, other than having the function of sterilizing, decolouring and deodorizing, hardly degraded organic substance can be aoxidized and improve wadding by also having The advantage of solidifying effect etc., and ozone will not remain or generate secondary pollution.
Hydrogen peroxide-ozone efficient oxidation system can generate HO2 -, it is the inducing agent that free radical OH is generated, free radical OH will cause chain reaction once generating, and accelerate oxidation rate, improve oxidation effectiveness.Therefore with conventional oxidation system ratio Get up, hydrogen peroxide-ozone efficient oxidation system can further shorten the reaction time, improve working efficiency.
Above-described embodiment is merely illustrative of the technical solution of the present invention, rather than its limitations;Although with reference to above-described embodiment Invention is explained in detail, it will be understood by those of ordinary skill in the art that:It still can be to aforementioned each implementation Technical solution recorded in example is modified or equivalent replacement of some of the technical features;And these modification or It replaces, the spirit and scope for various embodiments of the present invention technical solution that it does not separate the essence of the corresponding technical solution.

Claims (2)

1. a kind of preparation process of high purity heparin sodium, which is characterized in that include the following steps:
(1) proportionally every kilogram of crude heparin sodium is added in 8~10L purified waters and is dissolved, 3.0% (w/ of concentration is added V) sodium chloride is stirred 45~60 minutes and is filtered, removes the contamination precipitation of precipitation, obtain crude product filtered fluid;
(2) trypsase of 0.1%~0.2% (w/v) is added in the crude product filtered fluid obtained in step (1), adjusts pH value To 7.5~8.5, stir 1.5~2 hours, the foreign protein in heparin sodium is degraded to small-molecular peptides by trypsase, while making heparin Sodium molecule is dissociateed from the compound of heparin sodium-protein to be come, and enzymolysis liquid is obtained;
(3) pH value adjustment for the enzymolysis liquid that step (2) obtains will be passed through to 1.5~2.0, after stirring 30~45 minutes, using height The small-molecular peptides that fast low-temperature centrifugation removal zymoprotein and protein are degraded, obtain the few heparin sodium aqua of protein content;
(4) it is added the hydrogen peroxide of 1.5%~2.0% (w/v) in by step (3) obtained heparin sodium molten night, and by PH Value is adjusted to 8.5~9.5, stirs 3~4 hours, the colors in oxidation removal heparin sodium molten night, then high-speed low temperature from Gains in depth of comprehension are to heparin sodium oxidation solution;
(5) absolute ethyl alcohol is added in the heparin sodium oxidation solution obtained by step (4), by alcoholic strength according to percentage by volume tune It saves to 55~65 degree, and the sodium chloride of 1.0%~1.5% (w/v) is added in the solution, stir 1~1.5 hour and filter, obtain Heparin sodium sediment;
(6) acetone is added in the heparin sodium sediment obtained by step (5) to be dehydrated, and by vacuum drying, is made High purity heparin sodium.
2. a kind of preparation process of high purity heparin sodium according to claim 1, it is characterised in that:In the step (4) The hydrogen peroxide of 1.0%~1.5% (w/v) is added in heparin sodium molten night, and by pH value adjustment to 8.5~9.5, then passes to smelly Oxygen is aerated 2.5~3 hours, forms the efficient oxidation system of hydrogen peroxide-ozone, the pigment in oxidation removal heparin sodium molten night Substance and residual protein, then high-speed low temperature centrifuge to obtain heparin sodium oxidation solution.
CN201810202915.9A 2018-03-13 2018-03-13 A kind of preparation process of high purity heparin sodium Pending CN108456262A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810202915.9A CN108456262A (en) 2018-03-13 2018-03-13 A kind of preparation process of high purity heparin sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810202915.9A CN108456262A (en) 2018-03-13 2018-03-13 A kind of preparation process of high purity heparin sodium

Publications (1)

Publication Number Publication Date
CN108456262A true CN108456262A (en) 2018-08-28

Family

ID=63219874

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810202915.9A Pending CN108456262A (en) 2018-03-13 2018-03-13 A kind of preparation process of high purity heparin sodium

Country Status (1)

Country Link
CN (1) CN108456262A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109485750A (en) * 2018-12-12 2019-03-19 大英县添峰生物制品有限公司 A kind of heparin sodium low-temperature vacuum drying technology
CN109762079A (en) * 2019-01-15 2019-05-17 湖北亿诺瑞生物制药有限公司 A method of the separating-purifying Sulodexide bulk pharmaceutical chemicals from heparin byproduct
CN111057165A (en) * 2020-01-13 2020-04-24 苏州健飞肠衣有限公司 Preparation method of high-purity heparin sodium

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101831008A (en) * 2009-03-11 2010-09-15 四川茂森生物科技有限公司 New production process for refining crude heparin sodium
CN102225973A (en) * 2011-06-22 2011-10-26 郓城绅联生物科技有限公司 Production method for refined heparin sodium
CN105399867A (en) * 2015-12-07 2016-03-16 青岛九龙生物医药有限公司 Preparation method for heparin sodium
CN106084090A (en) * 2016-06-30 2016-11-09 郭舒洋 A kind of preparation method of refined heparin sodium

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101831008A (en) * 2009-03-11 2010-09-15 四川茂森生物科技有限公司 New production process for refining crude heparin sodium
CN102225973A (en) * 2011-06-22 2011-10-26 郓城绅联生物科技有限公司 Production method for refined heparin sodium
CN105399867A (en) * 2015-12-07 2016-03-16 青岛九龙生物医药有限公司 Preparation method for heparin sodium
CN106084090A (en) * 2016-06-30 2016-11-09 郭舒洋 A kind of preparation method of refined heparin sodium

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朱灵峰: "《水与废水处理新技术》", 31 August 2007, 西安地图出版社 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109485750A (en) * 2018-12-12 2019-03-19 大英县添峰生物制品有限公司 A kind of heparin sodium low-temperature vacuum drying technology
CN109762079A (en) * 2019-01-15 2019-05-17 湖北亿诺瑞生物制药有限公司 A method of the separating-purifying Sulodexide bulk pharmaceutical chemicals from heparin byproduct
CN109762079B (en) * 2019-01-15 2021-04-27 湖北亿诺瑞生物制药有限公司 Method for separating and purifying sulodexide bulk drug from heparin by-product
CN111057165A (en) * 2020-01-13 2020-04-24 苏州健飞肠衣有限公司 Preparation method of high-purity heparin sodium

Similar Documents

Publication Publication Date Title
FI79346C (en) FRAMSTAELLNING AV HYALURONSYRA MEDELST BAKTERIEKULTUR.
CN101550199B (en) Method for preparing sodium hyaluronate from hyaluronic acid zymotic fluid
CN108456262A (en) A kind of preparation process of high purity heparin sodium
ITMI20121184A1 (en) PROCESS FOR INDUSTRIAL PRODUCTION OF SODIUM IALURONATE (HANA) HIGHLY PURIFIED WITH CONTROLLED MOLECULAR WEIGHT
CN110105460B (en) Selenylation carboxymethyl pachyman and preparation method and application thereof
CN104788510A (en) Method for extracting glucosamine from self-fermentation liquid
US11155569B2 (en) Method of degrading polysaccharide using ozone
JPH04158796A (en) Production of aqueous solution of sodium hyaluronate
CN102070727A (en) Extraction method of sodium heparin
CN108359022B (en) Preparation method of lentinan
CN110804108A (en) Preparation method of water-soluble alginate for in vivo implantation
CN1284800C (en) Highly sulfacted derivatives of K5 polysaccharide and their preparation
CN101089021B (en) Process of separating and extracting hyaluronic acid from microbial fermented liquid
CN109762079B (en) Method for separating and purifying sulodexide bulk drug from heparin by-product
JP5713995B2 (en) Method for purifying hyaluronic acid and / or salt thereof
WO2013132506A1 (en) Process for the purification of hyaluronic acid salts (ha) from fermentation broth
CN110922506A (en) High-clarity heparin sodium
CN111620961A (en) Method for extracting ganoderan from ganoderma lucidum spore powder
CN106905442B (en) Preparation method of micromolecular beta-1, 3-glucan for improving immunity of hepatitis patients
CN115739031B (en) Application of chitosan or derivatives thereof in removal of endotoxin in gelatin
CN102603926B (en) New preparing process of high-titer heparin sodium
KR20000036774A (en) Preparing Methode for Aqueous Chitosan
WO2021112333A1 (en) Method for producing high-yield collagen with off-flavor removed therefrom
CN102993335A (en) Heparin sodium balance extraction method
CN112661797A (en) Glucosamine hydrochloride with low water activity as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180828